ABCB6 and acute myeloid leukemia: (3) BCRP was the third identified major drug efflux pump in the ABC family, and elevated BCRP levels are associated with treatment failure of chemotherapy in cancers such as acute myelogenous leukemia (AML) and breast cancer 62, 73.